126 related articles for article (PubMed ID: 8791059)
1. Glutathione S-transferase and multidrug-resistant phenotype in transitional cell carcinoma of the bladder.
Akdaş A; Türkeri LN; Küllü S; Tarcan T; Sakr W; Grignon DJ
Eur Urol; 1996; 29(4):483-6. PubMed ID: 8791059
[TBL] [Abstract][Full Text] [Related]
2. Correlative expression of glutathione S-transferase-pi and multidrug resistance associated protein in bladder transitional cell carcinoma.
Yang W; Zeng X; Chen C; Chen Z; Du G
J Tongji Med Univ; 2000; 20(4):311-4. PubMed ID: 12840920
[TBL] [Abstract][Full Text] [Related]
3. Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines.
Hour TC; Chen J; Huang CY; Guan JY; Lu SH; Hsieh CY; Pu YS
Anticancer Res; 2000; 20(5A):3221-5. PubMed ID: 11062746
[TBL] [Abstract][Full Text] [Related]
4. Glutathione-S-transferase pi expression in transitional cell carcinoma of the bladder.
Thomas DJ; Birch PJ; Vickers J; Robinson M; Clifford S; Hall A; Neal DE
Br J Urol; 1993 Nov; 72(5 Pt 2):740-3. PubMed ID: 8281406
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric determination of the multidrug resistant phenotype in transitional cell cancer of the bladder: implications and applications.
Benson MC; Giella J; Whang IS; Buttyan R; Hensle TW; Karp F; Olsson CA
J Urol; 1991 Oct; 146(4):982-6; discussion 986-7. PubMed ID: 1680203
[TBL] [Abstract][Full Text] [Related]
6. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
[TBL] [Abstract][Full Text] [Related]
7. Comparison of multidrug resistance gene expression levels with malignant potentials and influence of chemotherapy in urothelial cancers.
Kakehi Y; Wu WJ; Kim WJ; Arao S; Fukumoto M; Yoshida O
Int J Urol; 1995 Nov; 2(5):309-15. PubMed ID: 8749949
[TBL] [Abstract][Full Text] [Related]
8. Alterations in expression of the multidrug resistance-associated protein (MRP) gene in high-grade transitional cell carcinoma of the bladder.
Clifford SC; Neal DE; Lunec J
Br J Cancer; 1996 Mar; 73(5):659-66. PubMed ID: 8605104
[TBL] [Abstract][Full Text] [Related]
9. Synovial sarcoma: immunohistochemical expression of P-glycoprotein and glutathione S transferase-pi and clinical drug resistance.
Lopes JM; Bruland OS; Bjerkehagen B; Silva MC; Holm R; Pettersen EO; Solheim OP; Sobrinho-Simões M; Nesland JM
Pathol Res Pract; 1997; 193(1):21-36. PubMed ID: 9112270
[TBL] [Abstract][Full Text] [Related]
10. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
Volm M; Kästel M; Mattern J; Efferth T
Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of GST-Pi and HIF-1alpha in bladder carcinoma].
Deng JH; Bai JL; Ma PC; Zhang SS; Wan JH
Ai Zheng; 2006 Feb; 25(2):190-3. PubMed ID: 16480584
[TBL] [Abstract][Full Text] [Related]
12. Glutathione S-transferase and P-glycoprotein expressions in neuroblastoma.
Kutlik MT; Ayhan A; Göğüş S; Yalçin B; Cağlar M; Büyükpamukçu M
Pediatr Hematol Oncol; 2002; 19(5):337-45. PubMed ID: 12078865
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of gamma-glutamylcysteine synthetase and glutathione S-transferase genes in cisplatin-resistant bladder cancer cells with multidrug resistance phenotype.
Kotoh S; Naito S; Yokomizo A; Kohno K; Kuwano M; Kumazawa J
J Urol; 1997 Mar; 157(3):1054-8. PubMed ID: 9072542
[TBL] [Abstract][Full Text] [Related]
14. Absence of immunohistochemical metallothionein staining in bladder tumor specimens predicts response to neoadjuvant cisplatin, methotrexate and vinblastine chemotherapy.
Bahnson RR; Becich M; Ernstoff MS; Sandlow J; Cohen MB; Williams RD
J Urol; 1994 Dec; 152(6 Pt 2):2272-5. PubMed ID: 7966723
[TBL] [Abstract][Full Text] [Related]
15. Correlation between the expression of P-glycoprotein and multidrug-resistant phenotype in transitional cell carcinoma of the urinary tract.
Naito S; Sakamoto N; Kotoh S; Goto K; Matsumoto T; Kumazawa J
Eur Urol; 1992; 22(2):158-62. PubMed ID: 1362155
[TBL] [Abstract][Full Text] [Related]
16. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
17. DNA ploidy and P-glycoprotein expression as predictive factors of response to neoadjuvant chemotherapy for invasive bladder cancer.
Sandlow J; Cohen MB; Robinson RA; Dreicer R; Williams RD
Urology; 1994 Jun; 43(6):787-91. PubMed ID: 7910989
[TBL] [Abstract][Full Text] [Related]
18. Enhanced glutathione S-transferase activity and glutathione content in human bladder cancer. Followup study: influence of smoking.
Giralt M; Lafuente A; Pujol F; Mallol J
J Urol; 1993 Jun; 149(6):1452-4. PubMed ID: 8501786
[TBL] [Abstract][Full Text] [Related]
19. Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein 170, and glutathione S-transferase-pi in human lung tumors.
Volm M; Mattern J; Samsel B
Cancer; 1992 Aug; 70(4):764-9. PubMed ID: 1353700
[TBL] [Abstract][Full Text] [Related]
20. Expression of resistance-related proteins in nephroblastoma after chemotherapy.
Volm M; Mattern J; Stammler G; Royer-Pokora B; Schneider S; Weirich A; Ludwig R
Int J Cancer; 1995 Oct; 63(2):193-7. PubMed ID: 7591203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
